Guardant Health
GH
#1106
Rank
NZ$38.73 B
Marketcap
NZ$286.32
Share price
2.67%
Change (1 day)
65.78%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company